Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan, R.O.C.
Department of Anatomy, School of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
In Vivo. 2024 Nov-Dec;38(6):2955-2967. doi: 10.21873/invivo.13778.
BACKGROUND/AIM: Chronic low back pain (CLBP) significantly reduces quality of life and increases reliance on healthcare resources. Despite many individuals opting for vitamin D supplementation to alleviate CLBP, its efficacy remains debatable. This meta-analysis aimed to evaluate the potential benefits of vitamin D supplementation in treating this condition.
Adhering to PRISMA guidelines, we systematically reviewed the effectiveness of vitamin D supplementation in adults with CLBP, focusing exclusively on randomized controlled trials (RCTs). A comprehensive literature search was conducted up to May 2024 across multiple databases, including PubMed, Scopus, Cochrane Library, and Web of Science.
Ten RCTs meeting our inclusion criteria were analyzed. The results indicated that vitamin D supplementation did not significantly reduce pain scores compared to control groups (SMD: -0.130, 95%CI=-0.260 to 0.000; I=0%), regardless of participants' baseline vitamin D levels. Moreover, long-term supplementation showed no notable improvement in CLBP outcomes (SMD: -0.097, 95%CI=-0.290 to -0.097; I=19.878%). Additionally, supplementation with active forms of vitamin D (SMD: -0.321, 95%CI=-0.670 to 0.028; I=0.000%) did not result in significant pain relief for chronic lower back pain.
Vitamin D supplementation does not substantially alleviate CLBP. Nevertheless, it may still be considered as part of a comprehensive treatment plan. Further research is necessary to explore its long-term effects and the underlying mechanisms that may explain the observed lack of benefit.
背景/目的:慢性下腰痛(CLBP)显著降低生活质量并增加对医疗保健资源的依赖。尽管许多人选择补充维生素 D 来缓解 CLBP,但它的疗效仍存在争议。本荟萃分析旨在评估维生素 D 补充剂治疗这种疾病的潜在益处。
根据 PRISMA 指南,我们系统地回顾了维生素 D 补充剂在成人 CLBP 中的有效性,仅关注随机对照试验(RCT)。我们对多个数据库(包括 PubMed、Scopus、Cochrane 图书馆和 Web of Science)进行了全面的文献检索,检索截至 2024 年 5 月。
纳入的 10 项 RCT 进行了分析。结果表明,与对照组相比,维生素 D 补充剂并未显著降低疼痛评分(SMD:-0.130,95%CI=-0.260 至 0.000;I=0%),无论参与者的基线维生素 D 水平如何。此外,长期补充维生素 D 对 CLBP 结局没有明显改善(SMD:-0.097,95%CI=-0.290 至 -0.097;I=19.878%)。此外,补充活性形式的维生素 D(SMD:-0.321,95%CI=-0.670 至 0.028;I=0.000%)并不能显著缓解慢性下腰痛的疼痛。
维生素 D 补充剂不能显著缓解 CLBP。然而,它仍可被视为综合治疗计划的一部分。需要进一步研究来探索其长期效果和可能解释观察到的益处缺乏的潜在机制。